A prescription is a legal document with direct patient safety implications. It should be accurate, tamper-proof and legible. In 2024, across most of the GCC, prescriptions are none of these things — they are handwritten on paper, subject to alteration and frequently misread by pharmacists who must decipher handwriting under time pressure.
The data on paper prescription errors
A 2023 study published in a regional pharmacy journal found that approximately 31% of paper prescriptions presented at UAE pharmacies contained at least one error — wrong dose, missing drug name, illegible instructions or incomplete patient details. Of these, the pharmacist detected and queried 74%. The remaining 26% were dispensed.
Separately, prescription alteration — patients or third parties modifying a paper prescription to change the drug, dose or quantity — is estimated by the UAE pharmaceutical authority to affect between 3% and 5% of controlled medication prescriptions annually.
The digital solution
Digital, verified prescriptions solve both problems. A prescription issued digitally cannot be altered without invalidating the verification code. It is always legible. It can be checked against the patient's allergy profile and current medications at the point of issuance. And it creates a permanent, auditable record of every prescribing decision.
Adoption challenges
The barriers to digital prescription adoption in the GCC are not technical — the technology exists and works. They are regulatory (prescription law in several GCC countries still requires a physical signature), cultural (doctor and pharmacist habits built over decades) and infrastructural (pharmacies need the software to receive and verify digital prescriptions). We're working on all three.